150 related articles for article (PubMed ID: 36910659)
1. LOXL1 and LOXL4 are novel target genes of the Zn
Hirabayashi D; Yamamoto KI; Maruyama A; Tomonobu N; Kinoshita R; Chen Y; Komalasari NLGY; Murata H; Gohara Y; Jiang F; Zhou J; Ruma IMW; Sumardika IW; Yamauchi A; Kuribayashi F; Toyooka S; Inoue Y; Sakaguchi M
Front Oncol; 2023; 13():1142886. PubMed ID: 36910659
[TBL] [Abstract][Full Text] [Related]
2. Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.
Koh M; Woo Y; Valiathan RR; Jung HY; Park SY; Kim YN; Kim HR; Fridman R; Moon A
Int J Cancer; 2015 Mar; 136(6):E508-20. PubMed ID: 25155634
[TBL] [Abstract][Full Text] [Related]
3. Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness.
Chen Y; Sumardika IW; Tomonobu N; Kinoshita R; Inoue Y; Iioka H; Mitsui Y; Saito K; Ruma IMW; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Kubo M; Putranto EW; Murakami T; Liu M; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
Neoplasia; 2019 Jul; 21(7):627-640. PubMed ID: 31100639
[TBL] [Abstract][Full Text] [Related]
4. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins.
Lu H; Wu Z; Wang Y; Zhao D; Zhang B; Hong M
Phytomedicine; 2022 Sep; 104():154291. PubMed ID: 35839735
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
[TBL] [Abstract][Full Text] [Related]
6. PKCα Modulates Epithelial-to-Mesenchymal Transition and Invasiveness of Breast Cancer Cells Through ZEB1.
Llorens MC; Rossi FA; García IA; Cooke M; Abba MC; Lopez-Haber C; Barrio-Real L; Vaglienti MV; Rossi M; Bocco JL; Kazanietz MG; Soria G
Front Oncol; 2019; 9():1323. PubMed ID: 31828042
[TBL] [Abstract][Full Text] [Related]
7. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer.
Lorenzatti G; Huang W; Pal A; Cabanillas AM; Kleer CG
J Cell Sci; 2011 May; 124(Pt 10):1752-8. PubMed ID: 21525039
[TBL] [Abstract][Full Text] [Related]
8. Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis.
Addison JB; Voronkova MA; Fugett JH; Lin CC; Linville NC; Trinh B; Livengood RH; Smolkin MB; Schaller MD; Ruppert JM; Pugacheva EN; Creighton CJ; Ivanov AV
Mol Cancer Res; 2021 May; 19(5):784-798. PubMed ID: 33500360
[TBL] [Abstract][Full Text] [Related]
9. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J
J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049
[TBL] [Abstract][Full Text] [Related]
11. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
[TBL] [Abstract][Full Text] [Related]
12. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide binding of transcription factor ZEB1 in triple-negative breast cancer cells.
Maturi V; Enroth S; Heldin CH; Moustakas A
J Cell Physiol; 2018 Oct; 233(10):7113-7127. PubMed ID: 29744893
[TBL] [Abstract][Full Text] [Related]
14. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
15. YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m
Lin Y; Jin X; Nie Q; Chen M; Guo W; Chen L; Li Y; Chen X; Zhang W; Chen H; Jiang M; Xiao H; Zhang J; Fu F; Wang C
Ann Transl Med; 2022 Jan; 10(2):83. PubMed ID: 35282088
[TBL] [Abstract][Full Text] [Related]
16. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
[TBL] [Abstract][Full Text] [Related]
17. IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells.
Cao H; Zhang J; Liu H; Wan L; Zhang H; Huang Q; Xu E; Lai M
Oncotarget; 2016 Sep; 7(38):61183-61198. PubMed ID: 27533463
[TBL] [Abstract][Full Text] [Related]
18. Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators.
Rhodes LV; Tate CR; Segar HC; Burks HE; Phamduy TB; Hoang V; Elliott S; Gilliam D; Pounder FN; Anbalagan M; Chrisey DB; Rowan BG; Burow ME; Collins-Burow BM
Breast Cancer Res Treat; 2014 Jun; 145(3):593-604. PubMed ID: 24810497
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells.
Jägle S; Dertmann A; Schrempp M; Hecht A
Biochem Biophys Res Commun; 2017 Jan; 482(4):1226-1232. PubMed ID: 27923654
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231.
Liang W; Song S; Xu Y; Li H; Liu H
Mol Med Rep; 2018 May; 17(5):6711-6716. PubMed ID: 29512767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
